This inventor holds 4 USPTO granted patents. Top assignees: Teva Pharmaceutical Industries Limited, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 1994-1997.
Company Filing History:


Years Active: 1994-1997
Title: The Innovations of Alexander Veinberg
Introduction
Alexander Veinberg is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. With a total of 4 patents to his name, Veinberg's work has the potential to improve the quality of life for many patients.
Latest Patents
One of Veinberg's latest patents focuses on L-DOPA ethyl ester as a treatment for Parkinson's disease. This invention involves administering a composition that contains an active ingredient, which comprises L-DOPA ethyl ester in an amount of at least 97% by weight, along with L-DOPA in an amount of less than 1% by weight. Another patent details compositions of the ethyl ester of L-DOPA, which also includes a pharmaceutically acceptable carrier. This invention provides a method for preparing such a composition and outlines a treatment method for patients suffering from Parkinson's disease.
Career Highlights
Throughout his career, Alexander Veinberg has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Teva Pharmaceutical Industries Limited and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work in these organizations has contributed to advancements in medical treatments and research.
Collaborations
Veinberg has collaborated with esteemed colleagues, including Isaac Milman and Daphne Atlas. These partnerships have fostered innovation and have been instrumental in the development of his patented inventions.
Conclusion
Alexander Veinberg's contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease, highlight his role as an influential inventor. His innovative patents and collaborations with leading companies and colleagues underscore the importance of his work in advancing medical science.